Laurent Levy, Nanobiotix co-founder and CEO (via Nanobiotix)
Another biotech that went public in pandemic boom aims to weather the bear market through R&D cutbacks
The bear market is showing no signs of letting up, with a French biotech that IPO’ed during the pandemic boom feeling the heat.
Nanobiotix, a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
